1. Torre, LA, Bray, F, Siegel, RL, et al. Global cancer statistics, 2012. CA: a Cancer Journal for Clinicians 2015; 65: 87–108.
Google Scholar | Crossref | Medline | ISI2. Bibbins-Domingo, K, Grossman, DC, Curry, SJ, US Preventive Services Task Force et al. Screening for colorectal cancer: US preventive services task force recommendation statement. Jama 2016; 315: 2564–2575.
Google Scholar | Crossref | Medline3. von, KL, Patnick, J, Segnan, N, European Colorectal Cancer Screening Guidelines Working G et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013; 45: 51–59.
Google Scholar | Medline4. Brenner, H, Haug, U, Hundt, S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 2010; 105: 2457–2464.
Google Scholar | Crossref | Medline | ISI5. Ribbing Wilén, H, Blom, J, Höijer, J, et al. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives. Scand J Gastroenterol 2019; 54: 303–310.
Google Scholar | Crossref | Medline6. Toes-Zoutendijk, E, Kooyker, AI, Dekker, E, et al. Incidence of interval colorectal cancer after negative results from first-round fecal immunochemical screening tests, by cutoff value and participant sex and age. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2020; 18: 1493–1500.
Google Scholar | Crossref | Medline7. Giorgi Rossi, P, Carretta, E, Mangone, L, Colorectal Cancer Screening IMPATTO Working Group* et al. Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy. J Med Screen 2018; 25: 32–39.
Google Scholar | SAGE Journals | ISI8. Blom, J, Lowbeer, C, Elfstrom, KM, et al. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate. J Med Screen 2019; 26: 92–97.
Google Scholar | SAGE Journals | ISI9. Areia, M, Fuccio, L, Hassan, C, et al. Cost-utility analysis of colonoscopy or faecal immunochemical test for population-based organised colorectal cancer screening. United European Gastroenterol J 2019; 7: 105–113.
Google Scholar | SAGE Journals | ISI10. Aronsson, M, Carlsson, P, Levin, LA, et al. Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer. Br J Surg 2017; 104: 1078–1086.
Google Scholar | Crossref | Medline11. Ladabaum, U. Cost-Effectiveness of current colorectal cancer screening tests. Gastrointest Endosc Clin N Am 2020; 30: 479–497.
Google Scholar | Crossref | Medline12. Zhong, GC, Sun, WP, Wan, L, et al. Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: a systematic review and Meta-analysis. Gastrointestinal Endoscopy 2020; 91: 684–697.
Google Scholar | Crossref | Medline13. Meulen, MPV, Kapidzic, A, Leerdam, MEV, et al. Do men and women need to be screened differently with fecal immunochemical testing? A Cost-Effectiveness analysis. Cancer Epidemiol Biomarkers Prev 2017; 26: 1328–1336.
Google Scholar | Crossref | Medline14. Ness, RM, Holmes, AM, Klein, R, et al. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol 1999; 94: 1650–1657.
Google Scholar | Crossref | Medline15. Djalalov, S, Rabeneck, L, Tomlinson, G, et al. A review and Meta-analysis of colorectal cancer utilities. Med Decis Making 2014; 34: 809–818.
Google Scholar | SAGE Journals | ISI16. van Ballegooijen, M, Rutter, CM, Knudsen, AB, et al. Clarifying differences in natural history between models of screening: the case of colorectal cancer. Med Decis Making 2011; 31: 540–549.
Google Scholar | SAGE Journals | ISI17. Silva-Illanes, N, Espinoza, M. Critical analysis of markov models used for the economic evaluation of colorectal cancer screening: a systematic review. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research 2018; 21: 858–873.
Google Scholar | Crossref | Medline18. Pinsky, PF, Miller, A, Kramer, BS, et al. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol 2007; 165: 874–881.
Google Scholar | Crossref | Medline | ISI19. Schreuders, EH, Ruco, A, Rabeneck, L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut 2015; 64: 1637–1649.
Google Scholar | Crossref | Medline | ISI20. The Swedish National Board of Health and Welfare, webpage in Swedish available at: https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/dokument-webb/nationella-screeningprogram/screening-tjockandtarmscancer-rekommendation.pdf. cited 4th Nov 2020.
Google Scholar21. Thorlacius, H, Bjork, J, Ost, A, et al. Endoscopic surveillance after colorectal polypectomy. Lakartidningen 2017; 114: EHD6.
Google Scholar | Medline22. Moberger, P, Skoldberg, F, Birgisson, H. Evaluation of the swedish colorectal cancer registry: an overview of completeness, timeliness, comparability and validity. Acta Oncol 2018; 57: 1611–1621.
Google Scholar | Crossref | Medline23. The Swedish National Board of Health and Welfare , webpage in Swedish available at: https://www.socialstyrelsen.se/utveckla-verksamhet/gemensam-informationsstruktur/klassificering-och-koder/drg/drg-koder-och-definitioner/cited. 17th sept 2019.
Google Scholar24. Nguyen, SP, Bent, S, Chen, YH, et al. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and Meta-analysis. Clinical gastroenterology and hepatology: the official clinical practice journal of the. American Gastroenterological Association 2009; 7: 676–681 e1-3.
Google Scholar25. Ribbing Wilen, H, Blom, J, Hoijer, J, et al. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels. Journal of Gastroenterology and Hepatology 2019; 34: 103–112.
Google Scholar | Crossref | Medline26. Kapidzic, A, van der Meulen, MP, Hol, L, et al. Gender differences in fecal immunochemical test performance for early detection of colorectal neoplasia. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2015; 13: 1464–1471 e4.
Google Scholar | Crossref | Medline | ISI27. Imperiale, TF, Gruber, RN, Stump, TE, et al. Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps: a systematic review and Meta-analysis. Ann Intern Med 2019; 170: 319–329.
Google Scholar | Crossref | Medline28. Kooyker, AI, Toes-Zoutendijk, E, Opstal-van Winden, AWJ, et al. The second round of the dutch colorectal cancer screening program: Impact of an increased fit Cut-Off level on yield of screening. Int J Cancer 2020; 147: 1098–1106.
Google Scholar | Crossref | Medline29. Baldacchini, F, Bucchi, L, Giuliani, O, et al. Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2020. Article in press https://doi.org/.10.1016/j.cgh.2020.08.038
Google Scholar30. Koskenvuo, L, Malila, N, Pitkaniemi, J, et al. Sex differences in faecal occult blood test screening for colorectal cancer. Br J Surg 2019; 106: 436–447.
Google Scholar | Crossref | Medline31. Blom, J, Tornberg, S. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity. J Med Screen 2017; 24: 146–152.
Google Scholar | SAGE Journals | ISI32. Sarkeala, T, Farkkila, M, Anttila, A, et al. Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland. BMJ Open 2021; 11: e046667.
Google Scholar | Crossref | Medline33. Wieten, E, Schreuders, EH, Grobbee, EJ, et al. Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and Meta-analysis. Gut 2019; 68: 873–881.
Google Scholar | Crossref | Medline34. Lu, M, Luo, X, Li, N, et al. Diagnostic accuracy of fecal occult blood tests for detecting proximal versus distal colorectal neoplasia: a systematic review and Meta-Analysis. Clep 2019; Volume 11: 943–954.
Google Scholar | Crossref35. Digby, J, Fraser, CG, Carey, FA, et al. Faecal haemoglobin concentration is related to severity of colorectal neoplasia. J Clin Pathol 2013; 66: 415–419.
Google Scholar | Crossref | Medline | ISI36. Niedermaier, T, Balavarca, Y, Brenner, H. Stage-Specific sensitivity of fecal immunochemical tests for detecting colorectal cancer: Systematic review and Meta-Analysis. Am J Gastroenterol 2020; 115: 56–69.
Google Scholar | Crossref | Medline37. Benazzato, L, Zorzi, M, Antonelli, G, and the Veneto Screening Endoscopists Working Group et al. Colonoscopy-related adverse events and mortality in an italian organized colorectal cancer screening program. Endoscopy 2021; 53: 501–508.
Google Scholar | Crossref | Medline38. Kooyker, AI, Toes-Zoutendijk, E, Opstal-van Winden, AWJ, et al. Colonoscopy-Related mortality in a fecal immunochemical Test-Based colorectal cancer screening program. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the 2020;. American Gastroenterological Association. Article in press https://doi.org/10.1016/j.cgh.2020.07.066
Google Scholar | Crossref39. Saraste, D, Martling, A, Nilsson, PJ, et al. Complications after colonoscopy and surgery in a population-based colorectal cancer screening programme. J Med Screen 2016; 23: 135–140.
Google Scholar | SAGE Journals | ISI40. Vermeer, NCA, van der Valk, MJM, Snijders, HS, et al. Psychological distress and quality of life following positive fecal occult blood testing in colorectal cancer screening. Psycho‐Oncology 2020; 29: 1084–1091.
Google Scholar | Crossref | Medline41. Fritzell, K, Forsberg, A, Wangmar, J, et al. Gender, having a positive FIT and type of hospital are important factors for colonoscopy experience in colorectal cancer screening - findings from the SCREESCO study. Scand J Gastroenterol 2020; 55: 1354– 1359.
Google Scholar | Crossref | Medline42. Taupin, D, Chambers, SL, Corbett, M, et al. Colonoscopic screening for colorectal cancer improves quality of life measures: a population-based screening study. Health Qual Life Outcomes 2006; 4: 82.
Google Scholar | Crossref | Medline43. Haug, U, Engel, S, Verheyen, F, et al. Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from Germany. PloS One 2014; 9: e88407.
Google Scholar | Crossref | Medline